The switch from fetal γ-globin to adult β-globin is controlled by BCL11A. Genetic manipulation of BCL11A improves disease outcomes by turning γ-globin expression back on to compensate for mutant β- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback